FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2026
Back to search
Official data from USPTO
TENULI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/07/2026
Trademark type
Word
Nice classes
5
Filing date
07/11/2025
Registration date
04/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
CLARK, ANDREW T
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bausch Health Ireland Limited
Representatives
Jeremy Blackowicz Bausch Health Companies
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of blood conditionsdiseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditionsdiseasesdisorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of endocrine conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of hepatic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of immunological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of metabolic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of muscular conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of neurological conditionsdiseasesdisorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of renal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of urological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of viral diseases.
Publications
History of USPTO decisions and trademark events.
20 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/17/2026
PUBO
PUBLISHED FOR OPPOSITION
02/17/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2026
RFNT
REFUSAL PROCESSED BY IB
01/29/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/13/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/09/2026
RFRR
REFUSAL PROCESSED BY MPU
01/09/2026
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
12/18/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2025
CNRT
NON-FINAL ACTION WRITTEN
12/02/2025
DOCK
ASSIGNED TO EXAMINER
12/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
08/15/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/14/2025
Continuous trademark protection
Get notified about every new filing that threatens TENULI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.